Molecular Diagnostics Update for the Emerging (If Not Already Widespread) Sexually Transmitted Infection Agent

Erik Munson1

  • 1College of Health Sciences, Marquette University, Milwaukee, Wisconsin, USA erik.munson@marquette.edu.

Insights

Mycoplasma genitalium, an emerging sexually transmitted infection, can cause genital tract issues. Molecular diagnostic assays now aid in its detection, improving clinical and epidemiologic understanding of this important pathogen.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • Mycoplasma genitalium is an emerging sexually transmitted infection (STI) with potential for long-term genital tract complications.
  • Previous identification methods were challenging due to the organism's fastidious nature and antigenic complexity.
  • Advances in molecular diagnostics have overcome prior limitations in detecting M. genitalium.

Purpose of the Study:

  • To review the format and performance of available molecular diagnostic assays for Mycoplasma genitalium.
  • To assess how these assays have enhanced the clinical and epidemiologic understanding of M. genitalium infections.

Main Methods:

  • Review of commercially available DNA- and RNA-based amplification assays for M. genitalium.
  • Analysis of assay performance indices.

Main Results:

  • Multiple molecular diagnostic assays for M. genitalium are now available.
  • These assays demonstrate varying performance characteristics.
  • The widespread use of these assays has significantly improved the understanding of M. genitalium's clinical and epidemiological impact.

Conclusions:

  • Molecular diagnostics have revolutionized the detection of Mycoplasma genitalium.
  • Current assays provide valuable tools for clinical diagnosis and epidemiological studies.
  • Further understanding of M. genitalium infections is facilitated by these advanced detection methods.